Anti-OX40 antibody, its antigen-binding fragment, and pharmaceutical use

摘要

The present invention provides anti-OX40 antibodies, antigen-binding fragments thereof, and pharmaceutical uses. In addition, the present application provides chimeric and humanized antibodies comprising CDR regions derived from chimeric and humanized antibodies, anti-OX40 antibodies and antigen-binding fragments thereof, and pharmaceuticals comprising anti-OX40 antibodies and antigen-binding fragments thereof. The composition and its use as a cancer therapeutic agent are also provided. [Selection diagram] None